- Stratification of therapy according to molecular profile: It is likely that Wnt signaling pathway medulloblastomas will require less radiation than the current standard (34); desmoplastic medulloblastomas may be cured with chemotherapy alone (29).
- Signaling pathway inhibitors: These have been disappointing up to now; however, they may have a role in conjunction with chemotherapy in the future (28).
- Personalized chemotherapy based on molecular behavior: The potential to personalize treatment according to the response of growing individual tumors in vitro may be a previously untapped possibility for aggressive tumors in the future (48).
- Immunotherapy: This is currently being explored in clinical trials; this approach has been disappointing up to now (47).
- Antiangiogenesis therapy: This approach is continuing to be evaluated (5).
- Histone deacetylase inhibitors: These agents are currently in phase II clinical trials; their value remains to be determined (49).
Please create a free account or log in to read 'On The Horizon for Chemotherapy for Tumors in the Nervous System of Children'
Registration is free, quick and easy. Register and complete your profile and get access to the following:
- Full unrestricted access to The ISPN Guide
- Download pages as PDFs for offline viewing
- Create and manage page bookmarks
- Access to new and improved on-page references
